COVID-19: Toxicities of Potential Therapies

May 13, 2020 00:21:18
COVID-19: Toxicities of Potential Therapies
Critical Care Perspectives in Emergency Medicine
COVID-19: Toxicities of Potential Therapies

May 13 2020 | 00:21:18

/

Show Notes

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

October 06, 2017 00:33:20
Episode Cover

Noninvasive Ventilation for the Emergency Physician

We know NIV works well for patients with acute COPD or acute CHF exacerbations.  In this episode we discuss the evidence for NIV not...

Listen

Episode 0

July 08, 2022 00:22:56
Episode Cover

Restrictive Fluid Resuscitation in Sepsis? The CLASSIC Trial

IVF administration is central to the management of patients with sepsis.  Though the Surviving Sepsis Campaign recently downgraded its recommendation on the amount of...

Listen

Episode 0

May 15, 2019 00:29:21
Episode Cover

Refractory Vasodilatory Shock

Emergency medicine, critical care, and acute care providers evaluate, resuscitate, and manage patients with shock on a daily basis.  Despite initial efforts, a select...

Listen